EPCAM and liver cancer: Famous scholars from America [107] and Japan [108] have confirmed that peripheral blood EpCAM + CTC is the “seed” of liver cancer metastasis and recurrence and can be used as an independent predictor of metastasis and recurrence after liver cancer resection.